These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24028939)

  • 1. The α2-adrenoceptors mediating inhibition of the vasopressor sympathetic outflow in pithed rats: pharmacological correlation with α2A, α2B and α2C subtypes.
    Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2013 Oct; 718(1-3):245-52. PubMed ID: 24028939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological evidence that 5-HT1A/1B/1D, α2-adrenoceptors and D2-like receptors mediate ergotamine-induced inhibition of the vasopressor sympathetic outflow in pithed rats.
    Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Gutiérrez-Lara EJ; Centurión D
    Eur J Pharmacol; 2014 Oct; 740():512-21. PubMed ID: 24975101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evidence that alpha2A- and alpha2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats.
    Cobos-Puc LE; Villalón CM; Sánchez-López A; Lozano-Cuenca J; Pertz HH; Görnemann T; Centurión D
    Eur J Pharmacol; 2007 Jan; 554(2-3):205-11. PubMed ID: 17109851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific role of α2A - and α2B -, but not α2C -, adrenoceptor subtypes in the inhibition of the vasopressor sympathetic out-flow in diabetic pithed rats.
    Altamirano-Espinoza AH; Manrique-Maldonado G; Marichal-Cancino BA; Villalón CM
    Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):31-8. PubMed ID: 25407049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological identification of the α₂-adrenoceptor subtypes mediating the vasopressor responses to B-HT 933 in pithed rats.
    Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Manrique-Maldonado G; Villalón CM; Centurión D
    Eur J Pharmacol; 2012 Sep; 691(1-3):118-24. PubMed ID: 22713550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological identification of α1- and α2-adrenoceptor subtypes involved in the vasopressor responses induced by ergotamine in pithed rats.
    Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2013 Sep; 715(1-3):262-9. PubMed ID: 23707349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
    Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM
    Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine receptors mediating inhibition of the sympathetic vasopressor outflow in pithed rats: pharmacological correlation with the D(2) -like type.
    Manrique-Maldonado G; González-Hernández A; Marichal-Cancino BA; Villamil-Hernández MT; del Mercado OA; Centurión D; Villalón CM
    Basic Clin Pharmacol Toxicol; 2011 Dec; 109(6):506-12. PubMed ID: 21740529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of α
    Rivera-Mancilla E; Avilés-Rosas VH; Manrique-Maldonado G; Altamirano-Espinoza AH; Villanueva-Castillo B; MaassenVanDenBrink A; Villalón CM
    J Headache Pain; 2017 Oct; 18(1):104. PubMed ID: 29022279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats.
    Marichal-Cancino BA; Manrique-Maldonado G; Altamirano-Espinoza AH; Ruiz-Salinas I; González-Hernández A; Maassenvandenbrink A; Villalón CM
    Eur J Pharmacol; 2013 Dec; 721(1-3):168-77. PubMed ID: 24076186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective role of α
    Rivera-Mancilla E; Villanueva-Castillo B; Altamirano-Espinoza AH; Manrique-Maldonado G; Villalón CM
    Eur J Pharmacol; 2022 Aug; 929():175138. PubMed ID: 35798051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further analysis of the inhibition by agmatine on the cardiac sympathetic outflow: Role of the α
    Cobos-Puc L; Aguayo-Morales H; Ventura-Sobrevilla J; Luque-Contreras D; Chin-Chan M
    Eur J Pharmacol; 2017 Jun; 805():75-83. PubMed ID: 28315344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats.
    Cobos-Puc LE; Villalón CM; Ramírez-Rosas MB; Sánchez-López A; Lozano-Cuenca J; Gómez-Díaz B; MaassenVanDenBrink A; Centurión D
    Eur J Pharmacol; 2009 Aug; 616(1-3):175-82. PubMed ID: 19527708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evidence that metformin blocks the vasopressor responses mediated by stimulation of α
    de la Cruz SH; Medina-Terol GJ; Beltrán-Ornelas JH; Gomez CB; Morato-Valderrama Y; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2018 Feb; 820():130-137. PubMed ID: 29248426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α2A-adrenoceptors, but not nitric oxide, mediate the peripheral cardiac sympatho-inhibition of moxonidine.
    Cobos-Puc LE; Aguayo-Morales H; Silva-Belmares Y; González-Zavala MA; Centurión D
    Eur J Pharmacol; 2016 Jul; 782():35-43. PubMed ID: 27112661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evidence that NaHS inhibits the vasopressor responses induced by stimulation of the preganglionic sympathetic outflow in pithed rats.
    Centurión D; De la Cruz SH; Gutiérrez-Lara EJ; Beltrán-Ornelas JH; Sánchez-López A
    Eur J Pharmacol; 2016 Jan; 770():40-5. PubMed ID: 26643171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant role of the dopamine D3 receptor subtype for mediating the quinpirole-induced inhibition of the vasopressor sympathetic outflow in pithed rats.
    Ruiz-Salinas I; González-Hernández A; Manrique-Maldonado G; Marichal-Cancino BA; Altamirano-Espinoza AH; Villalón CM
    Naunyn Schmiedebergs Arch Pharmacol; 2013 May; 386(5):393-403. PubMed ID: 23420100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence for the role of histamine H3, but not H1, H2 or H4, receptors in immepip-induced inhibition of the rat cardioaccelerator sympathetic outflow.
    Pinacho-García M; Marichal-Cancino BA; Villalón CM
    Eur J Pharmacol; 2016 Feb; 773():85-92. PubMed ID: 26826593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evidence that spinal α(2C)- and, to a lesser extent, α(2A)-adrenoceptors inhibit capsaicin-induced vasodilatation in the canine external carotid circulation.
    Villalón CM; Galicia-Carreón J; González-Hernández A; Marichal-Cancino BA; Manrique-Maldonado G; Centurión D
    Eur J Pharmacol; 2012 May; 683(1-3):204-10. PubMed ID: 22445525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.